Close menu



Infliximab - Labelled (Arg,Lys) 13C15N


Quantification of Infliximab

Specific labelling

Arginine: 13C6,15N4>99%

Lysine: 13C6,15N2, >99%


Labelled Infliximab is a recombinant, stable isotope labelled, chimeric monoclonal antibody designed for use as an internal standard for quantitative analysis of Infliximab in plasma samples. Infliximab is a human TNF-α blocker that is used for the treatment of autoimmune diseases, such as Crohn’s disease and arthritis.

This product is for research use only and is not intended for diagnostic or therapeutic use.